Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Continuous Monitoring of Body Temperature in Mothers and Their Preterm Neonates (MonT NeoP)

5 oktober 2026 uppdaterad av: Medical University of Graz

Continuous Monitoring of Body Temperature in Mothers and Their Preterm Neonates During the Immediate Postnatal Transition - A Prospective Observational Pilot Study

Preterm babies are at increased risk of becoming too cold or too warm immediately after birth because they have an immature ability to regulate their body temperature. Maintaining a normal body temperature during the first minutes after birth is important because both low and high body temperatures are associated with an increased risk of complications. Current temperature monitoring is performed intermittently using conventional thermometers and does not provide continuous information about changes in body temperature.

This prospective observational pilot study aims to evaluate the feasibility of using the SteadyTemp® adhesive thermometer, a wireless, non-invasive temperature sensor, for continuous body temperature monitoring in preterm neonates (32+0 to 36+6 weeks of gestation) during the first 15 minutes after birth. The study will also compare temperatures recorded by the adhesive thermometer with a routine rectal temperature measurement and assess skin tolerability after removal of the adhesive patch. In addition, maternal body temperature will be continuously monitored during delivery to explore the relationship between maternal intrapartum temperature and neonatal temperature during the immediate postnatal transition.

The study hypothesizes that continuous temperature monitoring with the SteadyTemp® adhesive thermometer is feasible in preterm neonates, that the recorded temperatures agree with standard rectal temperature measurements, that the device is well tolerated without clinically relevant skin irritation, and that maternal intrapartum temperature correlates with neonatal body temperature during the immediate postnatal transition. The results of this pilot study will provide preliminary evidence to support future studies evaluating continuous, non-invasive temperature monitoring as a tool to improve thermal management of preterm neonates immediately after birth.

Studieöversikt

Status

Rekrytering

Intervention / Behandling

Detaljerad beskrivning

This is a prospective, multicenter, observational pilot study conducted at the Medical University of Graz, Austria, and the University Hospital Essen, Germany, to evaluate the feasibility, performance, and safety of continuous non-invasive body temperature monitoring using the SteadyTemp® wireless adhesive thermometer in moderately preterm neonates during the immediate postnatal transition. In addition, maternal intrapartum body temperature will be continuously monitored to explore the relationship between maternal and neonatal thermal regulation during the perinatal period.

Maintaining normothermia immediately after birth is a key component of neonatal care, particularly for preterm infants, who are at increased risk of thermal instability because of immature thermoregulation, limited brown adipose tissue, and a high surface area-to-volume ratio. Both hypothermia and hyperthermia are associated with increased neonatal morbidity and mortality. Conventional temperature assessment methods provide only intermittent measurements and do not permit continuous monitoring during the critical transition after birth. The SteadyTemp® adhesive thermometer is a wireless, skin-adherent device that continuously records body temperature and transfers the data via near-field communication (NFC). Although the device has previously been evaluated in adults and term neonates, its feasibility and performance in preterm neonates have not yet been investigated.

Following informed consent before delivery, the SteadyTemp® adhesive thermometer will be applied to the mother at least 10 minutes before birth to enable continuous intrapartum temperature monitoring. Immediately after birth, a second SteadyTemp® adhesive thermometer will be applied to the right axillary region of the preterm neonate and will continuously record body temperature during the first 15 minutes of postnatal transition. After completion of monitoring, the adhesive patch will be removed and neonatal skin integrity will be assessed using the Neonatal Skin Condition Scale (NSCS). As part of routine clinical care, a single rectal body temperature measurement will be obtained using the locally established reference thermometer and used for comparison with the temperature recorded by the investigational device. No study-specific therapeutic interventions are performed beyond application of the adhesive thermometers.

The study plans to enroll 80 participants, comprising 40 mother-preterm neonate pairs. The sample size was determined to provide adequate precision for estimating the feasibility of continuous temperature monitoring based on results from a previous pilot study in term neonates. The study is intended to generate preliminary evidence regarding device feasibility, agreement with routine clinical temperature measurements, skin tolerability, and the relationship between maternal and neonatal temperatures to support the design of future confirmatory studies.

Statistical analyses will primarily be descriptive. Continuous variables will be summarized using means and standard deviations or medians and interquartile ranges, as appropriate, while categorical variables will be presented as counts and percentages. Feasibility will be reported as the proportion of successful uninterrupted temperature recordings with corresponding 95% confidence intervals. Agreement between SteadyTemp® and rectal temperature measurements will be evaluated using Bland-Altman analysis and correlation analysis. Skin tolerability will be summarized descriptively, and changes in skin condition will be assessed when baseline assessments are available. Associations between maternal intrapartum temperature and neonatal temperature during the immediate postnatal transition will be explored using correlation analyses and longitudinal linear mixed models adjusted for relevant clinical variables. Statistical analyses will be performed using R software, and a two-sided p-value <0.05 will be considered statistically significant.

Study data will be recorded in paper-based case report forms using pseudonymized participant identifiers. Personal data will be handled in accordance with applicable data protection regulations and archived for the legally required retention period. Data quality will be ensured through double verification of data entry and independent monitoring according to a predefined monitoring plan. Source data verification will be performed by comparing case report forms with original medical records in accordance with ISO(International Organization for Standardization) 14155, ICH(International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use)-GCP(Good Clinical Practice), and applicable regulatory requirements. All study personnel will receive protocol-specific training, and written standard operating procedures will govern study conduct, data collection, monitoring, and use of the investigational device.

The Sponsor applies a risk-based quality management approach throughout the clinical investigation. Potential study-specific risks, protocol deviations, adverse events, and device deficiencies will be continuously monitored, documented, and managed in accordance with the clinical investigation plan and Regulation (EU) 2017/745. The study will be conducted in compliance with ISO 14155, ICH-GCP, the Declaration of Helsinki, and applicable national regulations governing clinical investigations of medical devices.

Studietyp

Observationell

Inskrivning (Beräknad)

40

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studiekontakt

Studera Kontakt Backup

Studieorter

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

  • Barn
  • Vuxen
  • Äldre vuxen

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Testmetod

Icke-sannolikhetsprov

Studera befolkning

The study population consists of preterm neonates born between 32+0 and 36+6 weeks of gestation and their mothers at the Department of Obstetrics and Gynaecology of the Medical University of Graz, Austria, and the University Hospital Essen, Germany. Eligible mother-preterm neonate pairs will be recruited before delivery after written informed consent has been obtained. Neonates will undergo routine postnatal care, with additional continuous temperature monitoring using the investigational device during the immediate postnatal transition.

Beskrivning

Inclusion Criteria:

  • Preterm neonates born between 32+0 and 36+6 weeks of gestation.
  • Written informed consent obtained from the mother (or legally authorized representative, where applicable according to national legislation) before delivery and before any study-specific procedures are performed.

Exclusion Criteria:

  • Gestational age <32+0 weeks or ≥37+0 weeks.
  • No decision to conduct full life support.
  • Written informed consent not obtained before delivery.
  • Congenital malformation.

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Observationsmodeller: COHORT
  • Tidsperspektiv: PROSPECTIVE

Kohorter och interventioner

Grupp / Kohort
Intervention / Behandling
Mother-Preterm Neonate Pairs

The study cohort consists of mother-preterm neonate pairs. Preterm neonates will undergo continuous body temperature monitoring using the SteadyTemp® adhesive thermometer during the first 15 minutes after birth, while mothers will undergo continuous intrapartum temperature monitoring during delivery. Neonatal temperatures will be compared with a routine single rectal temperature measurement, and maternal and neonatal temperature profiles will be explored to assess their relationship during the immediate postnatal transition.

SteadyTemp® (SteadySense GmbH, Graz, Austria) is a wireless, non-invasive adhesive thermometer designed for continuous body temperature monitoring. In this study, one adhesive thermometer will be applied to the mother's skin at least 10 minutes before delivery for continuous intrapartum temperature monitoring, and a second thermometer will be applied to the preterm neonate's right axillary region immediately after birth for continuous temperature monitoring during the first 15 minutes of postnatal transition. Temperature data are recorded continuously and transferred via near-field communication (NFC). The device is used in addition to standard clinical care and does not replace routine rectal temperature measurement, which serves as the clinical reference standard.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Feasibility of continuous body temperature monitoring using the SteadyTemp® adhesive thermometer in preterm neonates
Tidsram: 15 minutes

Feasibility will be assessed as the proportion of preterm neonates with successful placement of the SteadyTemp® adhesive thermometer and uninterrupted continuous body temperature recording during the first 15 minutes after birth.

15 minutes

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Agreement between SteadyTemp® and rectal body temperature measurements
Tidsram: 15 minutes after birth (at the time of routine rectal temperature measurement).

Agreement between the temperature recorded by the SteadyTemp® adhesive thermometer and the single routine rectal temperature measurement will be assessed using Bland-Altman analysis and correlation analysis.

15 minutes after birth (at the time of routine rectal temperature measurement).
Neonatal skin tolerability after application of the SteadyTemp® adhesive thermometer
Tidsram: Immediately after removal of the adhesive thermometer (15 minutes after birth).

Neonatal skin tolerability after application of the SteadyTemp® adhesive thermometer

Immediately after removal of the adhesive thermometer (15 minutes after birth).
Association between maternal intrapartum temperature and neonatal body temperature during immediate postnatal transition
Tidsram: From approximately 10 minutes before birth until 15 minutes after birth.

Correlation between continuously measured maternal intrapartum temperature and neonatal body temperature during the first 15 minutes after birth.

From approximately 10 minutes before birth until 15 minutes after birth.

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

5 augusti 2026

Primärt slutförande (Beräknad)

15 augusti 2028

Avslutad studie (Beräknad)

15 augusti 2028

Studieregistreringsdatum

Först inskickad

6 augusti 2026

Först inskickad som uppfyllde QC-kriterierna

6 augusti 2026

Första postat (Faktisk)

11 augusti 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

6 oktober 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

5 oktober 2026

Senast verifierad

1 oktober 2026

Mer information

Termer relaterade till denna studie

Andra studie-ID-nummer

  • 1222/2025

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

OBESLUTSAM

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera